Development of a Genetically-Attenuated Live Malaria Vaccine
Krystal Evans of The Walter and Eliza Hall Institute in Australia will knock out several proteins that support the expression of the major virulence factor for the malaria parasite. Their aim is create a genetically-attenuated live malaria vaccine that elicits a strong immune response against diverse strains of the parasite.